LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | WH-4-025 | 10.0 | uM | LJP5 | 3 | O07 | 72 | hr | 765 | 218 | 3124 | 0.0698 | -0.2319 |
| BT-20 | AT-7519 | 10.0 | uM | LJP6 | 1 | K01 | 72 | hr | 1334 | 219 | 3970 | 0.0552 | -0.4232 |
| BT-20 | A443654 | 10.0 | uM | LJP6 | 1 | I19 | 72 | hr | 1334 | 219 | 3970 | 0.0552 | -0.4232 |
| Hs 578T | AT-7519 | 10.0 | uM | LJP6 | 2 | K01 | 72 | hr | 765 | 219 | 3124 | 0.0701 | -0.2314 |
| Hs 578T | Mitoxantrone | 10.0 | uM | LJP6 | 1 | C19 | 72 | hr | 765 | 223 | 3124 | 0.0714 | -0.2297 |
| MCF 10A | Alvocidib | 3.33 | uM | LJP6 | 1 | A14 | 72 | hr | 1694 | 224 | 11155 | 0.0201 | -0.1554 |
| Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 3 | C20 | 72 | hr | 765 | 225 | 3124 | 0.0720 | -0.2289 |
| BT-20 | GSK1059615 | 10.0 | uM | LJP6 | 1 | C01 | 72 | hr | 1334 | 228 | 3970 | 0.0574 | -0.4198 |
| Hs 578T | WH-4-025 | 10.0 | uM | LJP5 | 1 | O07 | 72 | hr | 765 | 229 | 3124 | 0.0733 | -0.2272 |
| MCF 10A | Withaferin A | 10.0 | uM | LJP6 | 1 | G13 | 72 | hr | 1694 | 231 | 11155 | 0.0207 | -0.1547 |
| Hs 578T | WH-4-025 | 10.0 | uM | LJP5 | 2 | O07 | 72 | hr | 765 | 231 | 3124 | 0.0739 | -0.2263 |
| BT-20 | A443654 | 10.0 | uM | LJP6 | 2 | I19 | 72 | hr | 1334 | 233 | 3970 | 0.0587 | -0.4179 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 3 | C19 | 72 | hr | 2543 | 239 | 5578 | 0.0428 | -0.7592 |
| Hs 578T | Mitoxantrone | 10.0 | uM | LJP6 | 2 | C19 | 72 | hr | 765 | 240 | 3124 | 0.0768 | -0.2225 |
| Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 2 | C20 | 72 | hr | 765 | 243 | 3124 | 0.0778 | -0.2213 |
| MCF 10A | Withaferin A | 10.0 | uM | LJP6 | 2 | G13 | 72 | hr | 1694 | 244 | 11155 | 0.0219 | -0.1533 |
| BT-20 | A443654 | 10.0 | uM | LJP6 | 3 | I19 | 72 | hr | 1334 | 246 | 3970 | 0.0620 | -0.4130 |
| Hs 578T | A443654 | 10.0 | uM | LJP6 | 1 | I19 | 72 | hr | 765 | 246 | 3124 | 0.0787 | -0.2200 |
| Hs 578T | Canertinib | 10.0 | uM | LJP6 | 3 | H07 | 72 | hr | 765 | 246 | 3124 | 0.0787 | -0.2200 |
| Hs 578T | A443654 | 10.0 | uM | LJP6 | 3 | I19 | 72 | hr | 765 | 247 | 3124 | 0.0791 | -0.2196 |
| MCF 10A | Withaferin A | 10.0 | uM | LJP6 | 3 | G13 | 72 | hr | 1694 | 248 | 11155 | 0.0222 | -0.1529 |
| BT-20 | CGP60474 | 3.33 | uM | LJP6 | 1 | G02 | 72 | hr | 1334 | 251 | 3970 | 0.0632 | -0.4111 |
| Hs 578T | CGP60474 | 3.33 | uM | LJP6 | 1 | G02 | 72 | hr | 765 | 253 | 3124 | 0.0810 | -0.2170 |
| BT-20 | AT-7519 | 3.33 | uM | LJP6 | 1 | K02 | 72 | hr | 1334 | 254 | 3970 | 0.0640 | -0.4099 |
| MCF 10A | Alvocidib | 0.37 | uM | LJP6 | 1 | A16 | 72 | hr | 1694 | 255 | 11155 | 0.0229 | -0.1521 |